| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |